BAFNAPHARM

Bafna Pharmaceuticals Limited has submitted to the Exchange a copy of Details of Related party transactions In compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.

Bafna Pharmaceuticals Limited has informed the Exchange regarding Disclosure under Regulation 23(9) of SEBI ( LODR) Regulations 2015-Details of Related Party transactions.

Bafna Pharmaceuticals Limited has informed the Exchange regarding Corrigendum to Postal Ballot Notice dated January 07, 2017.

Bafna Pharmaceuticals Limited has informed the Exchange that the trading window for dealing with securities of the Company will be closed for the employees & Directors w.e.f. June 10, 2016 to till date of the Board Meeting (both days inclusive).

Bafna Pharmaceuticals Limited has informed the Exchange that the Company confirms that as per the Company's internal code for Prevention of Insider Trading, the trading window for dealing in the securities of the Company by the Directors and employees will remain closed from the date of receipt of the communication till 48 hours after the announcement of financial results made the public, i.e. June 1, 2016.

Bafna Pharmaceuticals Limited has informed the Exchange that the trading window for dealing in securities of the Company by the Directors and employees will remain closed from January 28, 2016 and shall be opened 48 (Forty Eight) hours after the financials results are approved by the Board of Directors on February 11, 2016.

Bafna Pharmaceuticals Limited has informed the Exchange that the trading window for dealing in securities of the Company by the Directors and employees will remain closed from the date of receipt of this communication till 48 hours after the announcement of the results made to the public.

Bafna Pharmaceuticals Limited has informed the Exchange that the trading window for dealing in securities of the Company by the Directors and employees will remain closed from the date of receipt of this communication till 48 hours after the announcement of the results made to the public.

Bafna Pharmaceuticals Limited has informed the Exchange regarding "Disclosure under SEBI (Prohibition of Insider Trading) Regulations 2015".

Bafna Pharmaceuticals Limited has informed the Exchange that the trading window for dealing in securities of the Company by the Directors and employees will remain closed from the May 14, 2015 till 48 hours after the announcement of financial results made to the public.

Bafna Pharmaceuticals Limited has informed the Exchange that the trading window for dealing with securities of the Company will be closed for the employees & Directors w.e.f. February 2, 2015 till the date of Board Meeting (both days inclusive). It will reopen after 24 hours of the publication of the results.

Bafna Pharmaceuticals Limited has informed the Exchange that the trading window for dealing with securities of the Company will be closed for the employees & Directors w.e.f. October 27, 2014 till the date of Board Meeting (both days inclusive).